Related Experiment Video

Updated: Dec 23, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.1K

Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells

Chuan Chen1, Zhu Han2, Minjie Yang3

  • 1Faculty of Basic Medical Sciences, Jiujiang University, Jiujiang.

Medicine
|April 26, 2020
PubMed

Insights

Xiakemycin A (XKA) induces apoptosis in hepatic cancer cells. This pyranonaphthoquinone antibiotic activates key apoptotic pathways, inhibiting cancer cell proliferation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Xiakemycin A (XKA), a pyranonaphthoquinone antibiotic, exhibits antitumor properties.
  • The precise mechanism of cell death induced by XKA is not well understood.

Purpose of the Study:

  • To investigate the type of cell death induced by Xiakemycin A (XKA) in hepatic cancer cells.
  • To elucidate the molecular pathways involved in XKA-mediated cell death.

Main Methods:

  • HepG2 cells were treated with XKA.
  • Apoptotic features were assessed using Hoechst 33342 staining, Annexin V-FITC/propidium iodide double staining, and Western blot analysis.
  • Mitochondrial membrane potential and reactive oxygen species generation were measured via flow cytometry.

Main Results:

  • XKA treatment led to a dose-dependent increase in chromatin condensation, reactive oxygen species generation, and Annexin V/propidium iodide staining.
  • XKA significantly decreased mitochondrial membrane potential.
  • Western blot analysis revealed increased p53 expression and cleavage of PARP, caspase-3, and caspase-9 in XKA-treated cells.

Conclusions:

  • Xiakemycin A (XKA) induces apoptosis in HepG2 hepatic cancer cells.
  • The apoptotic pathway activation, including p53 and caspase cascades, is responsible for XKA's antiproliferative effects.

More Related Videos

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

17.7K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.0K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K